Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0001
-0.0005 (-83.33%)
Jun 17, 2024, 12:20 PM EDT - Market closed
Q BioMed Market Cap
Q BioMed has a market cap or net worth of $14.51 thousand as of July 3, 2024. Its market cap has decreased by -99.05% in one year.
Market Cap
14.51K
Enterprise Value
n/a
1-Year Change
-99.05%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since July 3, 2019, Q BioMed's market cap has decreased from $21.25M to $14.51K, a decrease of -99.93%. That is a compound annual growth rate of -76.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 28, 2024 | 108.73 | -99.75% |
| Dec 29, 2023 | 43.49K | -96.12% |
| Dec 30, 2022 | 1.12M | -91.20% |
| Dec 31, 2021 | 12.73M | -46.77% |
| Dec 31, 2020 | 23.91M | -36.38% |
| Dec 31, 2019 | 37.58M | 76.84% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.38B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |